期刊
REVIEWS ON RECENT CLINICAL TRIALS
卷 12, 期 3, 页码 202-211出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1574887112666170803145955
关键词
Biotherapy; cancer stem cell; drug combination; drug resistance; neoplasm metastasis; personalized cancer therapy
资金
- Shanghai Science and Technology Foundation of High Educations [97A49]
Aim: The modality of anticancer drug combinations needs to be renovated from empirical into technical-supportive systems. Methods: To challenge past therapeutic routines, the new landscape may be established. Among the different areas of anticancer drug combination study, research in the fields of medical study is the most important one-including disciplinary of therapeutics in different cancer stages, modern genetic/molecular diagnostics, cancer bioinformatics, traditional Chinese medicine, mathematical data analysis, therapeutic toxicity monitor, personalized cancer medicine and so on. Discussion: This article addresses these types of cancer therapeutic management systems for clinical anticancer drug combination utilities. Conclusion: Future cancer drug combinational studies and clinical optimums must be implemented.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据